publication venue for
- Real-World Effectiveness of Upadacitinib for Treatment of Rheumatoid Arthritis in Canadian Patients: Interim Results from the Prospective Observational CLOSE-UP Study. 11:563-582. 2024
- Impact of the COVID-19 Pandemic on People Living with Rheumatoid Arthritis: Experiences and Preferences in Accessing Healthcare Across Five Countries. 11:257-268. 2024
- Long-Term Durability of Certolizumab Pegol in Patients with Rheumatoid Arthritis Over 5 Years: An Analysis of Pooled Clinical Trial Data. 10:693-706. 2023
- Efficacy and Safety of Upadacitinib in Patients with Psoriatic Arthritis: 2-Year Results from the Phase 3 SELECT-PsA 1 Study. 10:275-292. 2023
- Chronic Disease and Self-Injection: Ethnographic Investigations into the Patient Experience During Treatment. 4:445-463. 2017
- Randomized Crossover Comparison of Injection Site Pain with 40 mg/0.4 or 0.8 mL Formulations of Adalimumab in Patients with Rheumatoid Arthritis. 3:257-270. 2016
- The Tissue-Selective Estrogen Complex: A Review of Current Evidence. 2:47-58. 2015